PhD Student, BioMediTech, University of Tampere, Finland. Our research focuses on deciphering the mechanisms by which proprotein convertase enzymes (PCSK) regulate the immune system (Pesu et al, Blood. 2006 Aug 1;108(3):983-5., Pesu et al, Nature. 2008 Sep 11;455(7210):246-50., Turpeinen et al, J Biol Chem. 2013 Dec 20;288(51):36610-23). We are currently looking to recruit a PhD student to work at the BioMediTech, University of Tampere, Finland (www.uta.fi/bmthttp://www.uta.fi/bmt). Previous experience in animal models, flow cytometry and cell culture is advantageous. If interested, please send your application and CV in a single pdf file to Marko.Pesu@uta.fimailto:Marko.Pesu@uta.fi Closing date for applications is April 1, 2014.

Marko Pesu, MD, PhD Principal Investigator, Immunoregulation BioMediTech FI-33014 University of Tampere Finland e-mail: marko.pesu@uta.fimailto:marko.pesu@uta.fi tel:+358-50-3185817 fax:+358-3-35517332